Literature DB >> 25084763

Comparison of stopped Cox regression with direct methods such as pseudo-values and binomial regression.

Hans C van Houwelingen1, Hein Putter.   

Abstract

By far the most popular model to obtain survival predictions for individual patients is the Cox model. The Cox model does not make any assumptions on the underlying hazard, but it relies heavily on the proportional hazards assumption. The most common ways to circumvent this robustness problem are 1) to categorize patients based on their prognostic risk score and to base predictions on Kaplan-Meier curves for the risk categories, or 2) to include interactions with the covariates and suitable functions of time. Robust estimators of the t(0)-year survival probabilities can also be obtained from a "stopped Cox" regression model, in which all observations are administratively censored at t(0). Other recent approaches to solve this robustness problem, originally proposed in the context of competing risks, are pseudo-values and direct binomial regression, based on unbiased estimating equations. In this paper stopped Cox regression is compared with these direct approaches. This is done by means of a simulation study to assess the biases of the different approaches and an analysis of breast cancer data to get some feeling for the performance in practice. The tentative conclusion is that stopped Cox and direct models agree well if the follow-up is not too long. There are larger differences for long-term follow-up data. There stopped Cox might be more efficient, but less robust.

Entities:  

Mesh:

Year:  2014        PMID: 25084763     DOI: 10.1007/s10985-014-9299-3

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  5 in total

1.  Interpretability and importance of functionals in competing risks and multistate models.

Authors:  Per Kragh Andersen; Niels Keiding
Journal:  Stat Med       Date:  2011-11-14       Impact factor: 2.373

2.  On pseudo-values for regression analysis in competing risks models.

Authors:  Frederik Graw; Thomas A Gerds; Martin Schumacher
Journal:  Lifetime Data Anal       Date:  2008-12-03       Impact factor: 1.588

Review 3.  Pseudo-observations in survival analysis.

Authors:  Per Kragh Andersen; Maja Pohar Perme
Journal:  Stat Methods Med Res       Date:  2009-08-04       Impact factor: 3.021

4.  Pseudo-observations for competing risks with covariate dependent censoring.

Authors:  Nadine Binder; Thomas A Gerds; Per Kragh Andersen
Journal:  Lifetime Data Anal       Date:  2013-02-22       Impact factor: 1.588

5.  Absolute risk regression for competing risks: interpretation, link functions, and prediction.

Authors:  Thomas A Gerds; Thomas H Scheike; Per K Andersen
Journal:  Stat Med       Date:  2012-08-02       Impact factor: 2.373

  5 in total
  10 in total

Review 1.  Testing for center effects on survival and competing risks outcomes using pseudo-value regression.

Authors:  Yanzhi Wang; Brent R Logan
Journal:  Lifetime Data Anal       Date:  2018-07-05       Impact factor: 1.588

2.  Modeling restricted mean survival time under general censoring mechanisms.

Authors:  Xin Wang; Douglas E Schaubel
Journal:  Lifetime Data Anal       Date:  2017-02-21       Impact factor: 1.588

3.  Electronic Health Record-Based Screening for Substance Abuse.

Authors:  Farrokh Alemi; Sanja Avramovic; Mark D Schwartz
Journal:  Big Data       Date:  2018-09-19       Impact factor: 2.128

4.  Estimating the average treatment effect on survival based on observational data and using partly conditional modeling.

Authors:  Qi Gong; Douglas E Schaubel
Journal:  Biometrics       Date:  2016-05-18       Impact factor: 2.571

5.  Benchmarking survival outcomes: A funnel plot for survival data.

Authors:  Hein Putter; Dirk-Jan Eikema; Liesbeth C de Wreede; Eoin McGrath; Isabel Sánchez-Ortega; Riccardo Saccardi; John A Snowden; Erik W van Zwet
Journal:  Stat Methods Med Res       Date:  2022-03-08       Impact factor: 2.494

6.  A two-step method for variable selection in the analysis of a case-cohort study.

Authors:  P J Newcombe; S Connolly; S Seaman; S Richardson; S J Sharp
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

7.  MiR-20a, a novel promising biomarker to predict prognosis in human cancer: a meta-analysis.

Authors:  Donghua Huang; Yizhong Peng; Kaige Ma; Xiangyu Deng; Lu Tang; Doudou Jing; Zengwu Shao
Journal:  BMC Cancer       Date:  2018-11-29       Impact factor: 4.430

8.  MiR-19a as a prognostic indicator for cancer patients: a meta-analysis.

Authors:  Yizhong Peng; Donghua Huang; Kaige Ma; Xiangyu Deng; Zengwu Shao
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

9.  Investigation of MiR-92a as a Prognostic Indicator in Cancer Patients: a Meta-Analysis.

Authors:  Yizhong Peng; Donghua Huang; Xiangcheng Qing; Lu Tang; Zengwu Shao
Journal:  J Cancer       Date:  2019-07-23       Impact factor: 4.207

10.  Landmarking 2.0: Bridging the gap between joint models and landmarking.

Authors:  Hein Putter; Hans C van Houwelingen
Journal:  Stat Med       Date:  2022-01-31       Impact factor: 2.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.